Could a Placenta-Derived powder revolutionize wound healing after skin cancer surgery?

NCT ID NCT07680023

Not yet recruiting Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This phase 1 trial tests whether a powder made from human amnion membrane is safe and can improve healing of scalp wounds after Mohs surgery for skin cancer. About 20 adults with scalp wounds at least 4 cm² will receive either the amnion powder or standard ointment. Researchers will track infections, allergic reactions, pain, and how quickly the wound closes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: amnion membrane powder
What this could lead to: If safe and effective, this powder could speed up healing and reduce pain after Mohs surgery on the scalp.
What could go wrong: This is a very early, small phase 1 safety study with only 20 people. It may not show clear benefit, and risks like infection or allergic reaction are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for WOUND HEAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WOUND HEAL

Contacts and locations

Locations

Atrium Health Wake Forest Baptist

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.